TEASE Program Builds Case for Gildeuretinol in Stargardt - Quiz - MDSpire

TEASE Program Builds Case for Gildeuretinol in Stargardt

Philip J. Ferrone, MD, FASRS, reviewed data on gildeuretinol and discussed the ongoing NORTHSTAR pivotal trial at Retina World Congress.

  • By

  • Philip Ferrone, MD

  • May 14, 2026

  • 3 min

Share

Original Source(s)

TEASE Program Builds Case for Gildeuretinol in Stargardt

  • by Philip Ferrone, MD

  • May 14, 2026

Related Content

MIS-C: Diagnosis, Management, and Outcomes

Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study

The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001-P909)

  • November 5, 2025